Eric Shaff | executive |
Teresa Young | executive |
Lisa von Moltke | executive |
David Arkowitz | executive |
Jeffrey Jones | analyst |
David Ege | executive |
John Newman | analyst |
Matthew Henn | executive |
Tessa Romero | analyst |
John Peyton Bohnsack | analyst |
Chris Shibutani | analyst |
Kaey Nakae | analyst |
Ladies and gentlemen, good morning. My name is Abby, and will be your conference operator today. At this time, I would like to welcome everyone to the Seres Therapeutics Fourth Quarter 2023 Earnings Conference Call. Today's conference is being recorded. [Operator Instructions]